Showing results (61-70 of 426) with videos related to
Sort By:
Pageof 43
Antimicrobial Agents and Chemotherapy|August 22, 2000
Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infectionsE J Goldstein, D M Citron, C V Merriam, et al.Antimicrobial Agents and Chemotherapy|May 29, 1999
Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infectionsE J Goldstein, D M Citron, C V Merriam, et al.Antimicrobial Agents and Chemotherapy|September 3, 1999
In vitro activity of gemifloxacin (SB 265805) against anaerobesE J Goldstein, D M Citron, Y Warren, et al.Antimicrobial Agents and Chemotherapy|October 30, 1999
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobesE J Goldstein, D M Citron, C V Merriam, et al.Antimicrobial Agents and Chemotherapy|May 1, 1997
Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolatesE J Goldstein, D M Citron, S Hunt Gerardo, et al.Antimicrobial Agents and Chemotherapy|July 1, 1997
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humansE J Goldstein, D M Citron, M Hudspeth, et al.Antimicrobial Agents and Chemotherapy|May 21, 1998
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humansE J Goldstein, D M Citron, S Hunt Gerardo, et al.The Journal of Antimicrobial Chemotherapy|May 13, 1998
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogensE J Goldstein, D M Citron, M Hudspeth, et al.Antimicrobial Agents and Chemotherapy|August 22, 2000
Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infectionsE J Goldstein, D M Citron, C Vreni Merriam, et al.The Laryngoscope|December 1, 1980
The non-value of preoperative and intraoperative cultures in predicting the bacteriology of subsequent wound infection in patients undergoing major head and neck cancer surgeryG D Becker, G J Parell, D F Busch, et al.Pageof 43